KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
KYTH was delisted on the 30th of September, 2015.
106 hedge funds and large institutions have $663M invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2014 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 34 reducing their positions, and 18 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
5% more capital invested
Capital invested by funds: $632M → $663M (+$31.9M)
9% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 34
4% less funds holding
Funds holding: 110 → 106 (-4)
11% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 18
84% less call options, than puts
Call options by funds: $482K | Put options by funds: $2.99M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$25.2M |
| 2 |
TAM
Tocqueville Asset Management
New York
|
+$6.63M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.82M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$3.72M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$3.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$12.4M |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$10.8M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$9.22M |
| 4 |
Jennison Associates
New York
|
-$8.32M |
| 5 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
-$5.18M |
KYTH Hedge Fund Activity: Q4 2014 in Review
106 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q4 2014, worth a combined $663M — up 5.1% from $632M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of KYTH and 16 opened new positions — a net loss of 2 holders — while 34 trimmed existing stakes and 37 added.
The largest buyer was OrbiMed, opening a new position worth an estimated $25.2M. The largest seller was Massachusetts Financial Services, cutting an estimated $12.4M.
- 106 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q4 2014, down from 110 in Q3 2014.
- Funds reported $663M of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q4 2014, up 5.1% quarter-over-quarter.
- 16 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q4 2014 and 18 closed out, a net change of -2 holders.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM buyer in Q4 2014 was OrbiMed, an estimated $25.2M added.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q4 2014 was Massachusetts Financial Services, an estimated $12.4M sold.
Based on aggregated 13F filings for Q4 2014.